• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Serine protease inhibitor Kazal-type 9 (SPINK9)

ACP17164

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17164 Target NameSPINK9
Target SynonymsSPINK9; LEKTI2Serine protease inhibitor Kazal-type 9; Lymphoepithelial Kazal-type-related inhibitor 2FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range20-86
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5DT21
Background Information
  • Uniprot Id

    Q5DT21

  • Target Species

    Human

  • Target Name

    SPINK9

  • Target Full Name

    Serine protease inhibitor Kazal-type 9

  • Target Function

    Serine protease inhibitor which specifically inhibits KLK5. May contribute to the regulation of the desquamation process in skin by inhibiting KLK5.

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Skin. Highly expressed at sites of hyperkeratosis. Also detected in thymus, tonsils, testis, pancreas, liver, placenta and brain. Expressed at stratum granulosum and stratum corneum at palmar and plantar sites (at protein level).

  • Target Synonyms

    SPINK9; LEKTI2Serine protease inhibitor Kazal-type 9; Lymphoepithelial Kazal-type-related inhibitor 2

Inquire Recombinant Human Serine protease inhibitor Kazal-type 9 (SPINK9) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification